Purine level regulation during energy depletion associated with graded excitatory stimulation in brain

Neurological Research

Volumn 27, Issue 2, 2005, Pages 139-148

  Shepel, P Nickolas ^a   Ramonet, David ^b   Stevens, Patrick ^b   Geiger, Jonathan D ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Adenosine; Adenylate energy charge; ATP; Glutamate; Microwave irradiation

Indexed keywords

ADENOSINE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; AMPA RECEPTOR; CELL SURFACE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; KAINIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN SLICE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DESENSITIZATION; ENERGY METABOLISM; MALE; MICROWAVE RADIATION; NERVE EXCITABILITY; NERVE FUNCTION; NERVE STIMULATION; NONHUMAN; PURINE METABOLISM; RAT; RECEPTOR AFFINITY;

ADENINE NUCLEOTIDES; ADENOSINE TRIPHOSPHATE; ANIMALS; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; CRANIAL IRRADIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; ENERGY METABOLISM; EXCITATORY AMINO ACID AGENTS; FUNCTIONAL LATERALITY; GLUTAMIC ACID; MALE; MICROWAVES; PURINES; RATS; RATS, SPRAGUE-DAWLEY; REGRESSION (PSYCHOLOGY); TIME FACTORS;

EID: 15244343358     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164105X21832     Document Type: Article

References (59)

1. Benington JH, Heller HC. Restoration of brain energy metabolism as the function of sleep. Prog Neurobiol 1995; 45: 347-360
2. Basheer R, Strecker RE, Thakkar MM, et al. Adenosine and sleepwake regulation. Prog Neurobiol 2004; 73: 379-396
3. Danbolt NC. Glutamate uptake. Prog Neurobiol 2001; 1: 1-105
4. Delaney SM, Geiger JD. Enhancement of NMDA-induced increases in levels of endogenous adenosine by adenosine deaminase and adenosine transport inhibition in rat striatum. Brain Res 1995; 1-2: 72-76
5. Delaney SM, Geiger JD. Levels of endogenous adenosine in rat striatum. II. Regulation of basal and N-methyl-D-aspartate-induced levels by inhibitors of adenosine transport and metabolism. J Pharmacol Exp Ther 1998; 2: 568-572
6. Delaney SM, Shepel PN, Geiger JD. Levels of endogenous adenosine in rat striatum. I. Regulation by ionotropic glutamate receptors, nitric oxide and free radicals. J Pharmacol Exp Ther 1998; 2: 561-567
7. Hoehn K, White TD. Role of excitatory amino acid receptors in K+- and glutamate-evoked release of endogenous adenosine from rat cortical slices. J Neurochem 1990; 1: 256-265
8. Pedata F, Pazzagli M, Pepeu G. Endogenous adenosine release from hippocampal slices: excitatory amino acid agonists stimulate release, antagonists reduce the electrically- evoked release. Naunyn-Schmied Arch Pharmacol 1991; 5: 538-543.
9. Craig CG, White TD. N-methyl-D-aspartate-and non-N-methyl-D-aspartate- evoked adenosine release from rat cortical slices: distinct purinergic sources and mechanisms of release. J Neurochem 1993; 3: 1073-1080
10. Schousboe A, Frandsen A, Drejer J. Evidence for evoked release of adenosine and glutamate from cultured cerebellar granule cells. Neurochem Res 1989; 9: 871-875
11. Li J, Iadecola C. Nitric oxide and adenosine mediate vasodilation during functional activation in cerebellar cortex. Neuropharmacol 1994; 11: 1453-1461
12. Pelligrino DA, Wang Q, Koenig HM, et al. Role of nitric oxide, adenosine, N-methyl-D-aspartate receptors, and neuronal activation in hypoxia-induced pial arteriolar dilation in rats. Brain Res 1995; 1: 61-70
13. Evans MC, Swan JH, Meldrum BS. An adenosine analogue, 2-chloroadenosine, protects against long term development of ischaemic cell loss in the rat hippocampus. Neurosci Lett 1987; 3: 287-292
14. Yoon KW, Rothman SM. Adenosine inhibits excitatory but not inhibitory synaptic transmission in the hippocampus. J Neurosci 1991; 5: 1375-1380
15. Flagmeyer I, Haas HL, Stevens DR. Adenosine A1 receptor-mediated depression of corticostriatal and thalamostriatal glutamatergic synaptic potentials in vitro. Brain Res 1997; 1: 178-185
16. Newby AC. Adenosine and the concept of 'retaliatory metabolites'. Trends Biochem Sci 1984; 9: 42-44
17. Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Ann Rev Neurosci 2001; 24: 31-55
18. von Lubitz DK, Ye W, McClellan J, et al. Stimulation of adenosine A3 receptors in cerebral ischemia. Neuronal death, recovery, or both? Ann NY Acad Sci 1999; 890: 93-106
19. Corradetti R, Lo Conte G, Moroni F, et al. Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur J Pharmacol 1984; 1-2: 19-26
20. Simpson RE, O'Regan MH, Perkins LM, et al. Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists. J Neurochem 1992; 5: 1683-1690
21. Heron A, Lasbennes F, Seylaz J. Adenosine modulation of amino acid release in rat hippocampus during ischemia and veratridine depolarization. Brain Res 1993; 1: 27-32
22. Bennett GC, Boarder MR. The effect of nucleotides and adenosine on stimulus-evoked glutamate release from rat brain cortical slices. Br J Pharmacol 2000; 3: 617-623
23. Finn SF, Swartz KJ, Beal MF. 2-Chloroadenosine attenuates NMDA, kainate, and quisqualate toxicity. Neurosci Lett 1991; 2: 191-194
24. Roucher P, Meric P, Correze JL, et al. Metabolic effects of R-phenylisopropyladenosine during reversible forebrain ischemia studied by in vivo 31P nuclear magnetic resonance spectroscopy. J Cereb Blood Flow Metab 1991; 3: 453-458
25. Perez-Pinzon MA, Mumford PL, Rosenthal M, et al. Anoxic preconditioning in hippocampal slices: role of adenosine. Neuroscience 1996; 3: 687-694
26. Pedata F, Corsi C, Melani A, et al. Adenosine extracellular brain concentrations and role of A2A receptors in ischemia. Ann NY Acad Sci 2001; 74-84
27. Abbracchio MP, Ceruti S, Brambilla R, et al. Modulation of apoptosis by adenosine in the central nervous system: a possible role for the A3 receptor. Pathophysiological significance and therapeutic implications for neurodegenerative disorders. Ann NY Acad Sci 1997; 825: 11-22
28. Ponten U, Ratcheson RA, Salford LG, et al. Optimal freezing conditions for cerebral metabolites in rats. J Neurochem 1973; 21: 1127-1138
29. Veech RL, Harris RL, Veloso D, et al. Freeze-blowing: A technique for the study of brain in vivo. J Neurochem 1973; 20: 183-188
30. Delaney SM, Geiger JD. Brain regional levels of adenosine and adenosine nucleotides in rats killed by high-energy focused microwave irradiation. J Neurosci Methods 1996; 2: 151-156
31. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press, 1986
32. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
33. Atkinson DE. The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochem 1968; 11: 4030-4034
34. Bridges RJ, Kavanaugh MP, Chamberlin AR. A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous system. Curr Pharm Des 1999; 5: 363-379
35. Pazzagli M, Pedata F, Pepeu G. Effect of K+ depolarization, tetrodotoxin, and NMDA receptor inhibition on extracellular adenosine levels in rat striatum. Eur J Pharmacol 1993; 1: 61-65
36. Bettler B, Mulle C. Review: neurotransmitter receptors. II. AMPA and kainate receptors. Neuropharmacology 1995; 2: 123-139
37. Nowak L, Bregestovski P, Ascher P, et al. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 1984; 5950: 462-465
38. Perkins MN, Stone TW. In vivo release of [3H]-purines by quinolinic acid and related compounds. Br J Pharmacol 1983; 2: 263-267
39. Hoehn K, White TD. N-methyl-D-aspartate, kainate and quisqualate release endogenous adenosine from rat cortical slices. Neuroscience 1990; 2: 441-450
40. Calabresi P, Centonze D, Gubellini P, et al. Synaptic transmission in the striatum: from plasticity to neurodegeneration. Prog Neurobiol 2000; 3: 231-265
41. White TD, Craig CG, Hoehn K. Extracellular adenosine, formed during low level NMDA receptor activation, provides an inhibitory threshold against further NMDA receptor-mediated neurotransmission in the cortex. Drug Dev Res 1993; 406-409
42. McBean GJ, Roberts PJ. Neurotoxicity of L-glutamate and DL-threo-3-hydroxyaspartate in the rat striatum. J Neurochem 1985; 1: 247-254
43. Zhang L, Rzigalinski BA, Ellis EF, et al. Reduction of voltage-dependent Mg2+ blockade of NMDA current in mechanically injured neurons. Science 1996; 5294: 1921-1923
44. Ferkany JW, Zaczek R, Coyle JT. Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors. Nature 1982; 5876: 757-759
45. Young AM, Crowder JM, Bradford HF. Potentiation by kainate of excitatory amino acid release in striatum: complementary in vivo and in vitro experiments. J Neurochem 1988; 2: 337-345
46. Novelli A, Reilly JA, Lysko PG, et al. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 1988; 1-2: 205-212
47. Zeevalk GD, Nicklas WJ. Evidence that the loss of the voltage-dependent Mg2+ block at the N-methyl-D-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism. J Neurochem 1992; 4: 1211-1220
48. Sitkovsky MV. Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. Biochem Pharmacol 2003; 4: 493-501
49. Mody I, MacDonald JF. NMDA receptor-dependent excitotoxicity: the role of intracellular Ca2+ release. Trends Pharmacol Sci 1995; 10: 356-359
50. Schulz JB, Henshaw DR, Siwek D, et al. Involvement of free radicals in excitotoxicity in vivo. J Neurochem 1995; 5: 2239-2247
51. Nakao N, Grasbon-Frodl EM, Widner H, et al. Antioxidant treatment protects striatal neurons against excitotoxic insults. Neuroscience 1996; 1: 185-200
52. Nicholls DG, Budd SL, Castilho RF, et al. Glutamate excitotoxicity and neuronal energy metabolism. Ann NY Acad Sci 1999; 1-12
53. Onodera H, Iijima K, Kogure K. Mononucleotide metabolism in the rat brain after transient ischemia. J Neurochem 1986; 6: 1704-1710
54. Verhaegen M, Iaizzo PA, Todd MM. A comparison of the effects of hypothermia, pentobarbital, and isoflurane on cerebral energy stores at the time of ischemic depolarization. Anesthesiology 1995; 5: 1209-1215
55. Wilson CJ. Morphology and synaptic connections of crossed corticostriatal neurons in the rat. J Comp Neurol 1987; 4: 567-580
56. Wilson CJ. Postsynaptic potentials evoked in spiny neostriatal projection neurons by stimulation of ipsilateral and contralateral neocortex. Brain Res 1986; 1-2: 201-213
57. Ruzicka BB, Jhamandas K. Elevation of Met-enkephalin-like immunoreactivity in the rat striatum and globus pallidus following the focal injection of excitotoxins. Brain Res 1990; 1-2: 227-239
58. Lerner-Natoli M, Rondouin G, Belaidi M, et al. N-[1-(2-thienyl)- cyclohexyl]-piperidine (TCP) does not block kainic acid- induced status epilepticus but reduces secondary hippocampal damage. Neurosci Lett 1991; 2: 174-178
59. van Lookeren Campagne M, Lucassen PJ, Vermeulen JP, et al. NMDA and kainate induce internucleosomal DNA cleavage associated with both apoptotic and necrotic cell death in the neonatal rat brain. Eur J Neurosci 1995; 7: 1627-1640